Solid Biosciences Inc (SLDB)
8.94
-0.36
(-3.87%)
USD |
NASDAQ |
May 17, 16:00
8.94
0.00 (0.00%)
After-Hours: 20:00
Solid Biosciences Cash from Operations (Quarterly): -25.19M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -25.19M |
December 31, 2023 | -20.82M |
September 30, 2023 | -17.90M |
June 30, 2023 | -27.46M |
March 31, 2023 | -28.00M |
December 31, 2022 | -34.48M |
September 30, 2022 | -20.43M |
June 30, 2022 | -15.88M |
March 31, 2022 | -27.19M |
December 31, 2021 | -20.87M |
September 30, 2021 | -18.42M |
June 30, 2021 | -17.10M |
March 31, 2021 | -21.37M |
December 31, 2020 | 1.307M |
September 30, 2020 | -15.56M |
Date | Value |
---|---|
June 30, 2020 | -13.07M |
March 31, 2020 | -29.27M |
December 31, 2019 | -21.24M |
September 30, 2019 | -19.24M |
June 30, 2019 | -26.30M |
March 31, 2019 | -25.93M |
December 31, 2018 | -21.40M |
September 30, 2018 | -15.29M |
June 30, 2018 | -16.33M |
March 31, 2018 | -17.17M |
December 31, 2017 | -13.98M |
September 30, 2017 | -9.439M |
June 30, 2017 | -9.607M |
March 31, 2017 | -10.20M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-34.48M
Minimum
Dec 2022
1.307M
Maximum
Dec 2020
-20.92M
Average
-20.85M
Median
Cash from Operations (Quarterly) Benchmarks
Sarepta Therapeutics Inc | -242.08M |
PTC Therapeutics Inc | 70.76M |
Capricor Therapeutics Inc | -1.268M |
Catalyst Pharmaceuticals Inc | 31.92M |
Pfizer Inc | 1.09B |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -38.49M |
Cash from Financing (Quarterly) | 107.24M |
Free Cash Flow | -92.54M |
Free Cash Flow Per Share (Quarterly) | -0.6642 |
Free Cash Flow Yield | -42.15% |